News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
A Profitable Q1 Leaves Gilead CEO Money to Go Shopping for Possible M&As
May 1, 2015
·
5 min read
Drug Development
Gilead, Achillion Race to Grab Market Share As HCV Populations Abound
April 29, 2015
·
5 min read
Biotech Bay
Three Things To Watch With Gilead’s Q1 Earnings
April 28, 2015
·
1 min read
Deals
Why a Gilead/Vertex Deal Makes More and More Sense
April 28, 2015
·
3 min read
Drug Development
Merck & Co. Poised To Enter Oral HCV Market Dominated by Gilead and AbbVie
April 24, 2015
·
2 min read
Drug Development
Gilead Offers Free Drugs in Georgia in Hep C Eradication Experiment
April 23, 2015
·
2 min read
BioCapital
Buy Vertex Now for $45B Or Risk It All, Analyst Tells Gilead
April 21, 2015
·
2 min read
Deals
Three Biotechs Well-Positioned for M&A: Gilead, Celgene, and Biogen
April 14, 2015
·
2 min read
Drug Development
Will AbbVie’s HCV Candidates Threaten Gilead?
April 9, 2015
·
8 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Gilead Prices $3 Billion of Senior Unsecured Notes
May 14, 2026
·
3 min read
Press Releases
Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026
May 14, 2026
·
13 min read
Press Releases
Gilead Sciences Announces First Quarter Financial Results
May 8, 2026
·
19 min read
Press Releases
Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
May 8, 2026
·
8 min read
Press Releases
Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences
May 1, 2026
·
1 min read
Press Releases
U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir
April 29, 2026
·
12 min read
Press Releases
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
April 28, 2026
·
7 min read
Press Releases
Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
April 23, 2026
·
1 min read
Press Releases
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
April 17, 2026
·
8 min read
Press Releases
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
April 17, 2026
·
6 min read
